Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Improving Continence in People With Inflammatory Bowel Disease: Active Case Finding and a Randomised Controlled Trial
Brief Summary: Inflammatory Bowel Disease (IBD) affects 250,000 adults in the United Kingdom (UK) and causes bouts of diarrhoea which are hard to control. Over a quarter of patients experience extremely distressing faecal incontinence (FI). Even when the disease is in remission, the majority of patients live in fear of not finding a toilet in time. This curtails their activities and quality of life. The National Institute for Clinical Excellence (NICE 2007) has issued national guidance on actively asking patients about FI and a step-wise care plan for managing FI. However, this has not been evaluated in people with IBD, the vast majority of whom do not ask for help, even when they have frequent FI.

Across six expert centres in the UK, the investigators will perform 3 linked studies: \[1\] The investigators will screen people with IBD, offering the opportunity to obtain help with bowel control. The investigators will compare uptake of a postal approach versus response to a proactive face-to-face asking approach at a physical or telephone clinical appointment. \[2\] The investigators will conduct a randomised controlled trial (RCT) comparing two different approaches (IBD nurse specialist plus self-help booklet versus self-help booklet alone) to see which one produces the best results in terms of reductions in FI, other symptoms, costs and quality of life at 6 months after intervention. Booklet group participants may access the nurse intervention at 6 months if they wish, when the RCT is finished. \[3\] Interviews will be performed at the end of the intervention, gathering patient views and preferences and staff perspectives via Qualitative interviews and free text questionnaire comments, to enable a rich understanding and interpretation of our results.

The investigators will disseminate the results widely to people with IBD and health professionals and take active steps to embed successful interventions in NHS services, having gained sound evidence on how many people want help, whether intervention is effective in improving FI, and patient and staff views on interventions.


Options:
A: Arm Label: Educational Video; Type: EXPERIMENTAL; Interventions: Other: Educational video | Arm Label: Usual Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Educational video; Assigned to Arm(s): Educational Video
B: Arm Label: Group 1 (IBD Nurse CONSULT + BOOKLET); Type: EXPERIMENTAL; Interventions: Other: IBD nurse intervention | Arm Label: Group 2 (BOOKLET alone); Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: IBD nurse intervention; Assigned to Arm(s): Group 1 (IBD Nurse CONSULT + BOOKLET)
C: Arm Label: HealthPROMISE users; Type: EXPERIMENTAL; Interventions: Other: HealthPROMISE users | Arm Label: Control Group; Type: PLACEBO_COMPARATOR; Interventions: Other: Control Group | Intervention Type: OTHER; Name: HealthPROMISE users; Assigned to Arm(s): HealthPROMISE users | Intervention Type: OTHER; Name: Control Group; Assigned to Arm(s): Control Group
D: Arm Label: Standard of Care; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Weekly Home Monitoring; Type: EXPERIMENTAL; Interventions: Behavioral: Home Monitoring | Arm Label: Home Monitoring Every Other Week; Type: EXPERIMENTAL; Interventions: Behavioral: Home Monitoring | Intervention Type: BEHAVIORAL; Name: Home Monitoring; Assigned to Arm(s): Weekly Home Monitoring | Intervention Type: BEHAVIORAL; Name: Home Monitoring; Assigned to Arm(s): Home Monitoring Every Other Week

Answer: B